An investigational drug known as APT102 significantly reduced damage to heart muscle from a heart attack and minimized the risk of bleeding during follow-up treatments, according to an animal study…

Amyotrophic lateral sclerosis (Lou Gehrig's disease) is in the popular media because celebrities are dumping buckets of ice on their heads to raise awareness. Researchers probably wish they…

Generex Biotechnology Corporation has announced publication of a follow-up study from a Phase I clinical trial of the immunotherapeutic agent AE37 in patients with prostate cancer. The study…

A recent study conducted by Mayo Clinic researchers recommends laparoscopic cholecystectomies (surgical removal of the gallbladder) for pediatric patients suffering from gallstones and other…

Rheumatoid arthritis is a condition that causes painful inflammation of several joints in the body - the joint capsule becomes swollen, and the disease can also destroy cartilage and bone as it…

Frogs, dogs, whales, snails can all do it, but humans and primates can't. Regrow nerves after an injury, that is — while many animals have this ability, humans don't. But new research from the Salk…

XBiotech has begun its European Phase III study using its novel cancer drug Xilonix™ for the treatment of colorectal cancer. Xilonix is an antiobody works to block a number of processes that tumors…

Results  presented at the 2014 World Transplant Congress evaluated the safety and efficacy of CSL Behring's C1 Inhibitor (C1-INH) concentrate in preventing antibody-mediated rejection following…

Achalasia is a rare disease, affecting 1 in 100,000 people, characterized by a loss of nerve cells in the esophageal wall and manifested as chest pain during eating, weight loss, and regurgitation of…

New York, NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. has published results from the long-term, randomized, active control Phase 3 study of Zerenex (ferric citrate), their investigational…